Vaidyanathan, VenkateshKarunasinghe, WannakuwattewadugeKrishnamurthy, VKao, CH-JNaidu, VijayPallati, RWang, ATran, BaoKallingappa, PrasannaJabed, AnowerShahid, Syed MuhammadMasters, JWall, ClareNarayanan, AFerguson, Lynnette2018-11-212017-12-01Zealand Medical Journal 130(1466):96-99 01 Dec 20170028-8446http://hdl.handle.net/2292/44538Prostate cancer is an important health burden to the healthcare system of any country. However, with the current prostate-specific antigen biomarker having low predictive value even for diagnostic purposes, the challenge is still open to tackle this chronic disease. There have been a number of studies which have indicated and encouraged a multi-directional approach to combat this disease. We have been carrying out a multi-directional approach in order to identify certain New Zealand-specific factors which may be drivers for this cancer and its aggressive forms. These will be explained in further detail in this research letter.Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htmhttp://www.nzma.org.nz/journal/contributeJournal ArticleCopyright: New Zealand Medical Association29197908http://purl.org/eprint/accessRights/OpenAccess1175-8716